circRNA-SORE is transmitted to specific sensitive cells, which can prevent the breakdown of YBX1, a key cancer protein catalyzed by PRP19, and then inhibit the activation of related downstream factors (e.g., AKT, Raf1, ERK, etc.), thus spreading the resistance generated by chemotherapeutic drugs. The gene discussed is YBX1; the disease is cancer.